| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |